Literature DB >> 7565359

Collimator optimization for lesion detection incorporating prior information about lesion size.

S C Moore1, D J deVries, B Nandram, M F Kijewski, S P Mueller.   

Abstract

A Bayesian estimator has been developed as a paradigm for human observer performance in detecting lesions of unknown size in a uniform noisy background. The Bayesian observer used knowledge of the range of possible lesion sizes as a prior; its predictions agreed well with the results of a six-observer perceptual study. The average human response to changes in collimator resolution, as measured by the detectability index, dA, was tracked by the Bayesian detector's signal-to-noise ratio (SNR) somewhat better than by two other estimation models based, respectively, on lesser and greater degrees of lesion size uncertainty. As the range of possible lesion sizes increased, the Bayesian detector's SNR decreased and the optimal collimator resolution shifted towards better resolution. An analytic approximation for the variance of lesion activity estimates (which included the same prior) was shown to predict the variance of the Bayesian estimator over a wide range of collimator resolution values. Because the bias of the Bayesian estimator was small (< 1%), the analytic variance estimate permitted a rapid and convenient prediction of the Bayesian detection SNR. This calculation was then used to optimize the geometric parameters of a two-layer tungsten collimator being constructed from crossed grids for a new imaging detector. A Monte Carlo program was first run to estimate all contributions to the radial point-spread function for collimators of differing tungsten contents and spatial resolution values, imaging 140-keV photons emitted from the center of a 15-cm-diameter, water-filled attenuator. The optimal collimator design for detecting lesions with unknown diameters in the range 2.5-7.5 mm yielded a system resolution of approximately 8.5-mm FWHM, a geometric collimator efficiency of 1.21 x 10(-4), and a single-septum penetration probability of 1%.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565359     DOI: 10.1118/1.597466

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  7 in total

1.  A new design for a SPECT small-animal imager.

Authors:  D W Wilson; H H Barrett; L R Furenlid
Journal:  IEEE Nucl Sci Symp Conf Rec (1997)       Date:  2001-11-04

2.  Joint optimization of collimator and reconstruction parameters in SPECT imaging for lesion quantification.

Authors:  Sarah J McQuaid; Sudeepti Southekal; Marie Foley Kijewski; Stephen C Moore
Journal:  Phys Med Biol       Date:  2011-11-07       Impact factor: 3.609

3.  Image Reconstruction for a Partially Collimated Whole Body PET Scanner.

Authors:  Adam M Alessio; Ruth E Schmitz; Lawrence R Macdonald; Scott D Wollenweber; Charles W Stearns; Steven G Ross; Alex Ganin; Thomas K Lewellen; Paul E Kinahan
Journal:  IEEE Trans Nucl Sci       Date:  2008-06       Impact factor: 1.679

4.  Comparison of simultaneous and sequential SPECT imaging for discrimination tasks in assessment of cardiac defects.

Authors:  C M Trott; J Ouyang; G El Fakhri
Journal:  Phys Med Biol       Date:  2010-11-03       Impact factor: 3.609

5.  Collimator optimization and collimator-detector response compensation in myocardial perfusion SPECT using the ideal observer with and without model mismatch and an anthropomorphic model observer.

Authors:  Michael Ghaly; Jonathan M Links; Eric C Frey
Journal:  Phys Med Biol       Date:  2016-02-19       Impact factor: 3.609

6.  Collimator optimization in myocardial perfusion SPECT using the ideal observer and realistic background variability for lesion detection and joint detection and localization tasks.

Authors:  Michael Ghaly; Yong Du; Jonathan M Links; Eric C Frey
Journal:  Phys Med Biol       Date:  2016-02-19       Impact factor: 3.609

7.  Collimator optimization in SPECT based on a joint detection and localization task.

Authors:  Lili Zhou; Gene Gindi
Journal:  Phys Med Biol       Date:  2009-06-26       Impact factor: 3.609

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.